Opyl Ltd
ASX:OPL
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Opyl Ltd
Common Shares Outstanding
Opyl Ltd
Common Shares Outstanding Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Common Shares Outstanding | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Opyl Ltd
ASX:OPL
|
Common Shares Outstanding
AU$193m
|
CAGR 3-Years
53%
|
CAGR 5-Years
45%
|
CAGR 10-Years
86%
|
|
|
Iress Ltd
ASX:IRE
|
Common Shares Outstanding
AU$185.9m
|
CAGR 3-Years
1%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
2%
|
|
|
WiseTech Global Ltd
ASX:WTC
|
Common Shares Outstanding
AU$336m
|
CAGR 3-Years
1%
|
CAGR 5-Years
1%
|
CAGR 10-Years
N/A
|
|
|
TechnologyOne Ltd
ASX:TNE
|
Common Shares Outstanding
AU$326.4m
|
CAGR 3-Years
0%
|
CAGR 5-Years
0%
|
CAGR 10-Years
0%
|
|
|
Linius Technologies Ltd
ASX:LNU
|
Common Shares Outstanding
AU$6.2B
|
CAGR 3-Years
46%
|
CAGR 5-Years
36%
|
CAGR 10-Years
50%
|
|
|
Iris Energy Ltd
NASDAQ:IREN
|
Common Shares Outstanding
$258.1m
|
CAGR 3-Years
67%
|
CAGR 5-Years
36%
|
CAGR 10-Years
N/A
|
|
Opyl Ltd
Glance View
Opyl Ltd. is an information technology company. The company is headquartered in St Kilda, Victoria. The firm is focused on executing the change in direction into digital health, rebuilding the research and development pipeline to deliver solutions for the global health and life sciences sector. The firm has built a Opin, which is clinical trial recruitment platform that leverages social media, search engine optimization technologies and artificial intelligence science, matching patients directly to clinical trials. The firm is also developing Clinical trial prediction and protocol design tool. The firm subsidiaries include ShareRoot Inc, ShareRoot (Australian Ops) Pty Ltd, Opyl Services and Ludomade, Inc.
See Also
What is Opyl Ltd's Common Shares Outstanding?
Common Shares Outstanding
193m
AUD
Based on the financial report for Dec 31, 2024, Opyl Ltd's Common Shares Outstanding amounts to 193m AUD.
What is Opyl Ltd's Common Shares Outstanding growth rate?
Common Shares Outstanding CAGR 10Y
86%
Over the last year, the Common Shares Outstanding growth was 55%. The average annual Common Shares Outstanding growth rates for Opyl Ltd have been 53% over the past three years , 45% over the past five years , and 86% over the past ten years .
